TexasScholarWorks
    • Login
    • Submit
    View Item 
    •   Repository Home
    • Student Works
    • Honors Theses
    • View Item
    • Repository Home
    • Student Works
    • Honors Theses
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Advances in a C. elegans model of Alzheimer's disease for drug screening against neurodegeneration

    Thumbnail
    View/Open
    Thesis_Gabrielle_Zuniga05-2016.pdf (916.2Kb)
    Date
    2015-04
    Author
    Zuniga, Gabrielle
    Share
     Facebook
     Twitter
     LinkedIn
    Metadata
    Show full item record
    Abstract
    Alzheimer’s disease (AD) is the sixth leading cause of death in the United States, yet no treatment effectively prevents, halts or reverses the disease. Progress in developing treatments is hampered by the extensive time required for traditional mouse models of AD to age before displaying histological hallmarks of AD. We set out to test whether a novel transgenic model of AD using the nematode Caenorhabditis elegans may be used to more rapidly determine efficacy of candidate treatments through high throughput screening of behaviors. Our lab previously showed that antagonists for the conserved Sigma-2 receptor (Sig2R) are protective against age- dependent degeneration of cholinergic neurons caused by the human plaque protein, amyloid precursor protein (APP), in this model. To investigate how inhibition of Sig2R protects neurons, we tested whether knockdown of Sig2R via RNA interference prevented decline of two behaviors that depend on these cholinergic neurons. We found that RNAi treatment normalized one of the two behaviors in this AD model suggesting that the antagonists act against the Sig2R in vivo for neuroprotection. The success of this study suggests that this behavioral readout might be used to screen for additional pharmaceutical and genetic modifiers of Sig2R on neurodegeneration. In addition to developing this high throughput behavioral screening, we also built transgene components to generate an improved second generation C. elegans model of AD that conveniently tags the APP protein with mCherry for in vivo fluorescent visualization. Our results set the stage for further drug discovery using our C. elegans models of AD.
    Department
    Neuroscience
    Subject
    Alzheimer's disease
    Caenorhabditis elegans
    cholinergic neurons
    neurodegeneration
    sigma-2-receptor
    egg laying
    locomotion
    C. elegans
    amyloid precursor protein
    URI
    http://hdl.handle.net/2152/38188
    Collections
    • Honors Theses

    University of Texas at Austin Libraries
    • facebook
    • twitter
    • instagram
    • youtube
    • CONTACT US
    • MAPS & DIRECTIONS
    • JOB OPPORTUNITIES
    • UT Austin Home
    • Emergency Information
    • Site Policies
    • Web Accessibility Policy
    • Web Privacy Policy
    • Adobe Reader
    Subscribe to our NewsletterGive to the Libraries

    © The University of Texas at Austin

     

     

    Browse

    Entire RepositoryCommunities & CollectionsDate IssuedAuthorsTitlesSubjectsDepartmentsThis CollectionDate IssuedAuthorsTitlesSubjectsDepartments

    My Account

    Login

    Statistics

    View Usage Statistics

    Information

    About Contact Policies Getting Started Glossary Help FAQs

    University of Texas at Austin Libraries
    • facebook
    • twitter
    • instagram
    • youtube
    • CONTACT US
    • MAPS & DIRECTIONS
    • JOB OPPORTUNITIES
    • UT Austin Home
    • Emergency Information
    • Site Policies
    • Web Accessibility Policy
    • Web Privacy Policy
    • Adobe Reader
    Subscribe to our NewsletterGive to the Libraries

    © The University of Texas at Austin